213 related articles for article (PubMed ID: 10988285)
21. Protein kinase A phosphorylation of the ryanodine receptor does not affect calcium sparks in mouse ventricular myocytes.
Li Y; Kranias EG; Mignery GA; Bers DM
Circ Res; 2002 Feb; 90(3):309-16. PubMed ID: 11861420
[TBL] [Abstract][Full Text] [Related]
22. Reduced level of serine(16) phosphorylated phospholamban in the failing rat myocardium: a major contributor to reduced SERCA2 activity.
Sande JB; Sjaastad I; Hoen IB; Bøkenes J; Tønnessen T; Holt E; Lunde PK; Christensen G
Cardiovasc Res; 2002 Feb; 53(2):382-91. PubMed ID: 11827689
[TBL] [Abstract][Full Text] [Related]
23. Threonine-17 phosphorylation of phospholamban: a key determinant of frequency-dependent increase of cardiac contractility.
Zhao W; Uehara Y; Chu G; Song Q; Qian J; Young K; Kranias EG
J Mol Cell Cardiol; 2004 Aug; 37(2):607-12. PubMed ID: 15276030
[TBL] [Abstract][Full Text] [Related]
24. Synthetic phosphopeptides enable quantitation of the content and function of the four phosphorylation states of phospholamban in cardiac muscle.
Ablorh NA; Dong X; James ZM; Xiong Q; Zhang J; Thomas DD; Karim CB
J Biol Chem; 2014 Oct; 289(42):29397-405. PubMed ID: 25190804
[TBL] [Abstract][Full Text] [Related]
25. Expression of slow skeletal troponin I in hearts of phospholamban knockout mice alters the relaxant effect of beta-adrenergic stimulation.
Wolska BM; Arteaga GM; Peña JR; Nowak G; Phillips RM; Sahai S; de Tombe PP; Martin AF; Kranias EG; Solaro RJ
Circ Res; 2002 May; 90(8):882-8. PubMed ID: 11988489
[TBL] [Abstract][Full Text] [Related]
26. The alpha-helical propensity of the cytoplasmic domain of phospholamban: a molecular dynamics simulation of the effect of phosphorylation and mutation.
Paterlini MG; Thomas DD
Biophys J; 2005 May; 88(5):3243-51. PubMed ID: 15764655
[TBL] [Abstract][Full Text] [Related]
27. Effects of increased systolic Ca(2+) and β-adrenergic stimulation on Ca(2+) transient decline in NOS1 knockout cardiac myocytes.
Roof SR; Biesiadecki BJ; Davis JP; Janssen PM; Ziolo MT
Nitric Oxide; 2012 Dec; 27(4):242-7. PubMed ID: 22960389
[TBL] [Abstract][Full Text] [Related]
28. CaMKII-mediated increased lusitropic responses to beta-adrenoreceptor stimulation in ANP-receptor deficient mice.
Yurukova S; Kilić A; Völker K; Leineweber K; Dybkova N; Maier LS; Brodde OE; Kuhn M
Cardiovasc Res; 2007 Mar; 73(4):678-88. PubMed ID: 17107670
[TBL] [Abstract][Full Text] [Related]
29. Phosphorylation states of phospholamban.
Colyer J
Ann N Y Acad Sci; 1998 Sep; 853():79-91. PubMed ID: 10603938
[TBL] [Abstract][Full Text] [Related]
30. The effect of isoproterenol on phospholamban-deficient mouse hearts with altered thyroid conditions.
Brittsan AG; Kiss E; Edes I; Grupp IL; Grupp G; Kranias EG
J Mol Cell Cardiol; 1999 Sep; 31(9):1725-37. PubMed ID: 10471356
[TBL] [Abstract][Full Text] [Related]
31. Site-specific phosphorylation of a phospholamban peptide by cyclic nucleotide- and Ca2+/calmodulin-dependent protein kinases of cardiac sarcoplasmic reticulum.
Karczewski P; Kuschel M; Baltas LG; Bartel S; Krause EG
Basic Res Cardiol; 1997; 92 Suppl 1():37-43. PubMed ID: 9202842
[TBL] [Abstract][Full Text] [Related]
32. Troponin I phosphorylation plays an important role in the relaxant effect of beta-adrenergic stimulation in mouse hearts.
Peña JR; Wolska BM
Cardiovasc Res; 2004 Mar; 61(4):756-63. PubMed ID: 14985072
[TBL] [Abstract][Full Text] [Related]
33. Basal and β-adrenergic regulation of the cardiac calcium channel CaV1.2 requires phosphorylation of serine 1700.
Fu Y; Westenbroek RE; Scheuer T; Catterall WA
Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16598-603. PubMed ID: 25368181
[TBL] [Abstract][Full Text] [Related]
34. Conformational changes within the cytosolic portion of phospholamban upon release of Ca-ATPase inhibition.
Li J; Bigelow DJ; Squier TC
Biochemistry; 2004 Apr; 43(13):3870-9. PubMed ID: 15049694
[TBL] [Abstract][Full Text] [Related]
35. Diminished basal phosphorylation level of phospholamban in the postinfarction remodeled rat ventricle: role of beta-adrenergic pathway, G(i) protein, phosphodiesterase, and phosphatases.
Huang B; Wang S; Qin D; Boutjdir M; El-Sherif N
Circ Res; 1999 Oct; 85(9):848-55. PubMed ID: 10532953
[TBL] [Abstract][Full Text] [Related]
36. Oligomeric interactions between phospholamban molecules regulate Ca-ATPase activity in functionally reconstituted membranes.
Yao Q; Chen LT; Li J; Brungardt K; Squier TC; Bigelow DJ
Biochemistry; 2001 May; 40(21):6406-13. PubMed ID: 11371203
[TBL] [Abstract][Full Text] [Related]
37. Mechanism of reversal of phospholamban inhibition of the cardiac Ca2+-ATPase by protein kinase A and by anti-phospholamban monoclonal antibody 2D12.
Chen Z; Akin BL; Jones LR
J Biol Chem; 2007 Jul; 282(29):20968-76. PubMed ID: 17548345
[TBL] [Abstract][Full Text] [Related]
38. Effects of mutant and antisense RNA of phospholamban on SR Ca(2+)-ATPase activity and cardiac myocyte contractility.
He H; Meyer M; Martin JL; McDonough PM; Ho P; Lou X; Lew WY; Hilal-Dandan R; Dillmann WH
Circulation; 1999 Aug; 100(9):974-80. PubMed ID: 10468529
[TBL] [Abstract][Full Text] [Related]
39. Combined phospholamban ablation and SERCA1a overexpression result in a new hyperdynamic cardiac state.
Zhao W; Frank KF; Chu G; Gerst MJ; Schmidt AG; Ji Y; Periasamy M; Kranias EG
Cardiovasc Res; 2003 Jan; 57(1):71-81. PubMed ID: 12504816
[TBL] [Abstract][Full Text] [Related]
40. Cardiac-specific overexpression of sarcolipin in phospholamban null mice impairs myocyte function that is restored by phosphorylation.
Gramolini AO; Trivieri MG; Oudit GY; Kislinger T; Li W; Patel MM; Emili A; Kranias EG; Backx PH; Maclennan DH
Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2446-51. PubMed ID: 16461894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
